High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies

A growing body of evidence shows that fragment crystallizable (Fc)-dependent antibody effector functions play an important role in protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To unravel the mechanisms that drive these responses, we analyzed the phagocytosis and complement deposition mediated by a panel of 482 human monoclonal antibodies (nAbs) neutralizing the original Wuhan virus, expressed as recombinant IgG1. Our study confirmed that nAbs no longer neutralizing SARS-CoV-2 Omicron variants can retain their Fc functions. Surprisingly, we found that nAbs with the most potent Fc function recognize the N-terminal domain, followed by those targeting class 3 epitopes in the receptor binding domain. Interestingly, nAbs direct against the class 1/2 epitopes in the receptor binding motif, which are the most potent in neutralizing the virus, were the weakest in Fc functions. The divergent properties of the neutralizing and Fc function-mediating antibodies were confirmed by the use of different B cell germlines and by the observation that Fc functions of polyclonal sera differ from the profile observed with nAbs, suggesting that non-neutralizing antibodies also contribute to Fc functions. These data provide a high-resolution picture of the Fc-antibody response to SARS-CoV-2 and suggest that the Fc contribution should be considered for the design of improved vaccines, the selection of therapeutic antibodies, and the evaluation of correlates of protection.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:121

Enthalten in:

Proceedings of the National Academy of Sciences of the United States of America - 121(2024), 3 vom: 16. Jan., Seite e2314730121

Sprache:

Englisch

Beteiligte Personen:

Paciello, Ida [VerfasserIn]
Maccari, Giuseppe [VerfasserIn]
Pantano, Elisa [VerfasserIn]
Andreano, Emanuele [VerfasserIn]
Rappuoli, Rino [VerfasserIn]

Links:

Volltext

Themen:

Antibodies
Antibodies, Neutralizing
B cell germlines
Epitopes
Fc function
Journal Article
SARS-CoV-2

Anmerkungen:

Date Completed 12.01.2024

Date Revised 24.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1073/pnas.2314730121

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366891154